Researchers Report Advance in Immune Therapy Against ALS
Federation of American Societies for Experimental Biology (FASEB)New research suggests that targeting autoimmune inflammation associated with amyotrophic lateral sclerosis (ALS) using two drugs, one of them already approved for multiple sclerosis, could be a promising approach for treatment.